We are a Precision Medicine company, focusing on patients to reveal the complex personal biology of chronic diseases
Location: United States, Massachusetts, Cambridge
Founded date: 2015
Investors 3
Mentions in press and media 10
| Date | Title | Description |
| 28.03.2025 | Polish Bioinformatics Firm Intelliseq Secures €4.5M to Revolutionize Genomic Analysis | In the realm of healthcare, data is the new gold. The Polish bioinformatics company Intelliseq has struck a rich vein, securing €4.5 million in funding to propel its genomic data analysis capabilities. This investment, led by Vinci HiTech a... |
| 28.03.2025 | Intelliseq secures €4.5M to enhance DNA analysis and genetic diagnostics | Polish bioinformatics company Intelliseq, has secured €4.5 million (PLN19 million) in its latest funding round. Clinical genomics transforms the way diseases are diagnosed and treated. Next-generation sequencing (NGS) has unlocked an unprec... |
| 21.03.2025 | The Long Shadow of Long COVID: Unraveling the Mystery of a Debilitating Condition | March 15th marked International Long COVID Awareness Day, a stark reminder of a condition that has ensnared at least 65 million people worldwide. Long COVID is not just a lingering cough or fatigue; it’s a complex web of symptoms that can t... |
| 17.03.2025 | International Long COVID Day highlights need for diagnostics as PrecisionLife unlocks genetic breakthroughs | March 15th marked International Long COVID Awareness Day. This debilitating condition is estimated to affect at least 65 million people and is increasing annually, creating a rising healthcare burden of over $1 trillion globally. Long COVID... |
| 30.05.2024 | Nexera Pharma Co., Ltd. Expand target disease areas through strategic R&D alliance with PrecisionLife | Nexera Pharma Co., Ltd. Expand target disease areas through strategic R&D alliance with PrecisionLife Aims to identify novel drug targets by expanding existing collaborations and leveraging new insights in the disease biology of autoimm... |
| 30.05.2024 | Nexera Pharma Co., Ltd. Expand target disease areas through strategic R&D alliance with PrecisionLife | - |
| 20.12.2023 | Absci, PrecisionLife Partner to Develop AI-Enabled Drug Pipeline | What You Should Know: – Absci, a generative AI drug creation company, and PrecisionLife, a pioneer in computational biology for complex chronic diseases, have announced a powerful partnership to develop a joint portfolio of potential therap... |
| 15.05.2023 | LifeArc announces strategic partnership with PrecisionLife as part of its Motor Neuron Disease Translational Challenge | London and Oxford, UK, 15 May 2023 – Self funded, not-for-profit medical research organisation LifeArc and techbio company PrecisionLife announce a strategic R&D collaboration to accelerate the discovery and development of targeted trea... |
| 07.10.2020 | New Innovation Centre in Warsaw: CIC Opens its Doors | Co-working spaces become increasingly popular in Poland Cambridge Innovation Center opened its Warsaw campus in May this year A flexible approach helps co-working spaces overcome difficulties caused by pandemic CIC brings innovative minds ... |
| - | PrecisionLife Continues Growth and Expansion With Acquisition of Danish Genomic Analytics Innovator GenoKey | OXFORD, England & AALBORG, Denmark--(BUSINESS WIRE)--Mar 24, 2021-- PrecisionLife today announces that it has acquired its long-term Danish technology development partner GenoKey ApS, bringing together the leaders in combinatorial analy... |